CRISPR Therapeutics Names A.J. Silver CFO, Succeeding Raju Prasad

PUBT · 2d ago
CRISPR Therapeutics Names A.J. Silver CFO, Succeeding Raju Prasad
  • CRISPR Therapeutics appointed its senior vice president of finance as chief financial officer, effective today.
  • Outgoing CFO Raju Prasad is leaving to pursue external opportunities.
  • The successor joined in October 2018 and had served as senior vice president of finance since January 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CRISPR Therapeutics AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610191605PRIMZONEFULLFEED9848665) on October 19, 2026, and is solely responsible for the information contained therein.